🇺🇸 FDA

Drug profile · INN

ciclesonide

ALVESCO

approved
US status
approved
Patents linked
4
News articles
0

Quick answer

ciclesonide (ALVESCO) is an FDA-listed pharmaceutical active ingredient. Route of administration: nasal. Current US regulatory status: approved.

Key facts

INN ciclesonide
Brand ALVESCO
Route NASAL
Formulation SPRAY

Related patents

Search patents →

  1. US 9422327

    Process for preparing crystalline ciclesonide with defined particle size

    Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8486923

    Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

    Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8481516

    Ciclesonide containing sterile aqueous suspension

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8435497

    Formoterol of and ciclesonide combination

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is ciclesonide?

ciclesonide (ALVESCO) is an FDA-listed pharmaceutical active ingredient. Route of administration: nasal. Current US regulatory status: approved.

What is the brand name for ciclesonide?

ALVESCO is a marketed brand name for ciclesonide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ciclesonide?

ciclesonide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.